Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GEHC vs GSK✓SelectedUSD · GSKGEHC vs GSK performance historyLatest closeAs of+2.22%11/18
Stock and ETF performance explorer

GEHC vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+14.7%
GSK return
+56.0%
Excess return
-41.3%
Maximum drawdown
-37.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+2.2%-1.3%+3.6%+2.7%
7D+1.3%-3.1%+4.4%+2.5%
30D+20.0%-0.9%+20.9%+20.2%
3M+15.3%-4.2%+19.4%+16.8%
6M+36.2%-1.6%+37.8%+36.4%
YTD+2.2%+2.6%-0.4%+2.2%
1Y+18.0%+6.2%+11.8%+17.0%
All+14.7%+56.0%-41.3%-6.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling